SME Central
Home / SME Stocks / Accretion Pharmaceuticals

Accretion Pharmaceuticals: IPO, Share Price and Results Since Listing

Accretion Pharmaceuticals listed on NSE Emerge on 21 May 2025 after an IPO at INR 101 a share. On 11 November 2026 the shares closed at INR 203.75, 101.73% above the issue price. For H1 FY2027 it reported revenue of INR 55.04 crore (+25.85% on a year earlier) and a profit after tax of INR 8.20 crore.

Key Facts

IPO dates
14 May 2025 to 16 May 2025
Issue price
INR 101
Issue size
INR 29.75 crore
Subscription
7.73 times
Lead manager
Jawa Capital Services Private Limited
Listing day
opened at INR 79 (-21.78%), closed at INR 82.95 (-17.87%)
Listed on NSE Emerge
21 May 2025
Symbol
ACCPL
Latest close
INR 203.75 on 11 November 2026
Against issue price
+101.73%
Lot size now
600 shares (INR 1,22,250 at the latest close)

Results Filed With NSE

Standalone figures, INR crore. Change compares with the same period a year earlier.

PeriodRevenueChangeProfit after taxEPS (INR)Filed
H1 FY202755.04+25.85%8.207.38after listing2 November 2026
H2 FY202645.89+18.24%4.924.42after listing8 May 2026
FY202689.63+56.21%9.679.03after listing8 May 2026
H1 FY202643.74โ€“4.754.61after listing14 November 2025
H2 FY202538.81โ€“4.335.30before listing11 June 2025
FY202557.38โ€“6.798.48before listing11 June 2025

Promoter Holding

Promoter holding has moved from 73.50% on 19 May 2025 to 73.52% on 30 September 2026 (+0.02 percentage points).

As ofPromotersPublic
30 September 202673.52%26.48%
30 June 202673.52%26.48%
31 March 202673.52%26.48%
31 December 202573.52%26.48%
30 September 202573.52%26.48%
30 June 202573.50%26.50%
19 May 202573.50%26.50%

Anchor Lock-ins

Lock-inEnds
30 days18 June 2025
90 days17 August 2025

Sources: NSE Emerge filings (results XBRL, shareholding pattern, board meetings), NSE daily price files, and IPO records. Prices are not adjusted for bonus issues or splits.